###begin article-title 0
###xml 45 48 45 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRP</italic>
Allelic spectrum of the natural variation in CRP
###end article-title 0
###begin p 1
###xml 762 765 762 765 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRP</italic>
###xml 768 771 768 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRP</italic>
###xml 1178 1181 1178 1181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRP</italic>
###xml 556 564 <span type="species:ncbi:9606">patients</span>
###xml 1571 1576 <span type="species:ncbi:9606">human</span>
With the recent completion of the International HapMap Project, many tools are in hand for genetic association studies seeking to test the common variant/common disease hypothesis. In contrast, very few tools and resources are in place for genotype-phenotype studies hypothesizing that rare variation has a large impact on the phenotype of interest. To create these tools for rare variant/common disease studies, much interest is being generated towards investing in re-sequencing either large sample sizes of random chromosomes or smaller sample sizes of patients with extreme phenotypes. As a case study for rare variant discovery in random chromosomes, we have re-sequenced ~1,000 chromosomes representing diverse populations for the gene C-reactive protein (CRP). CRP is an important gene in the fields of cardiovascular and inflammation genetics, and its size (~2 kb) makes it particularly amenable medical or deep re-sequencing. With these data, we explore several issues related to the present-day candidate gene association study including the benefits of complete SNP discovery, the effects of tagSNP selection across diverse populations, and completeness of dbSNP for CRP. Also, we show that while deep re-sequencing uncovers potentially medically relevant coding SNPs, these SNPs are fleetingly rare when genotyped in a population-based survey of 7,000 Americans (NHANES III). Collectively, these data suggest that several different types re-sequencing and genotyping approaches may be required to fully understand the complete spectrum of alleles that impact human phenotypes.
###end p 1
###begin title 2
Electronic Supplementary Material
###end title 2
###begin p 3
Supplementary material is available for this article at  and is accessible for authorized users.
###end p 3
###begin title 4
Introduction
###end title 4
###begin p 5
###xml 378 382 378 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">2005</xref>
###xml 486 490 486 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">2003</xref>
###xml 505 509 505 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR28">2003</xref>
###xml 612 616 612 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR34">2003</xref>
###xml 618 622 618 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR35">2005</xref>
###xml 651 655 651 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR18">2005</xref>
###xml 28 33 <span type="species:ncbi:9606">Human</span>
###xml 95 100 <span type="species:ncbi:9606">human</span>
###xml 165 170 <span type="species:ncbi:9606">human</span>
###xml 348 353 <span type="species:ncbi:9606">human</span>
Since the completion of the Human Genome Project, much emphasis has been placed on cataloguing human DNA variation and understanding its impact on susceptibility to human diseases. The most common form of sequence polymorphism is the single base substitution. Single nucleotide polymorphisms (SNPs) occur on average once every 180 basepairs in the human genome (Crawford et al. 2005). A catalogue of common DNA variation is now well-developed in at least one population (Carlson et al. 2003; Reich et al. 2003), and new resources provided by the International HapMap Project (The International HapMap Consortium 2003, 2005) and Perlegen (Hinds et al. 2005), among others, offer useful information and tools for genetic association studies for applying common SNPs in different population samples.
###end p 5
###begin p 6
###xml 340 344 340 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR21">2001</xref>
###xml 751 755 751 755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">1997</xref>
###xml 926 930 926 930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR26">2002</xref>
###xml 1163 1167 1163 1167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">2003</xref>
###xml 720 725 <span type="species:ncbi:9606">human</span>
###xml 892 897 <span type="species:ncbi:9606">human</span>
While public databases are useful for mining information about common SNPs, the databases are less useful and complete for rare variants. Rare sequence variants, defined here as having a minor allele frequency of <1%, are not well-described most likely because of the number of chromosomes required to discover them (Kruglyak and Nickerson 2001). It is possible that both common and rare variation will be required to aid investigators in developing approaches for successful genetic association study designs. For example, one common design for association studies, the common disease/common variant approach, assumes that common DNA variation rather than rare DNA variation is associated with susceptibility to common human diseases (Collins et al. 1997). However, many advocate the possibility that many rare variants, each with a small contribution, underlie the susceptibility to common human diseases (Pritchard and Cox 2002). The arguments are further complicated by study designs that genotype "tagSNPs" and rely on linkage disequilibrium to identify the causative SNP ("indirect") versus genotyping known nonsynonymous SNPs ("direct"; Botstein and Risch 2003).
###end p 6
###begin p 7
###xml 231 235 231 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">2005</xref>
###xml 335 338 335 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRP</italic>
###xml 341 344 341 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRP</italic>
###xml 590 594 590 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">2004</xref>
###xml 633 636 633 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRP</italic>
###xml 697 701 697 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2003</xref>
###xml 718 722 718 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR3">2000</xref>
###xml 738 742 738 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">2005</xref>
###xml 759 763 759 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR29">2004</xref>
###xml 780 784 780 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR36">2003</xref>
###xml 875 879 875 879 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR23">2005</xref>
###xml 936 939 936 939 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRP</italic>
###xml 1436 1441 <span type="species:ncbi:9606">human</span>
As views of common variation emerge, empirical data on how to obtain rare variation and its application in the context of a genetic association study are needed in this age where "medical" re-sequencing is becoming possible (Gibbs 2005). To provide these data, we have chosen to examine these issues using the gene C-reactive protein (CRP). CRP is an ideal model for deep or medical re-sequencing because it is a small gene (~2 kb) whose protein product is well studied as an established general marker for predicting cardiovascular disease and risk of myocardial infarction (Danesh et al. 2004). Furthermore, sequence variation for CRP has been described in several smaller studies (Brull et al. 2003; Cao and Hegele 2000; Kovacs et al. 2005; Russell et al. 2004; Wolford et al. 2003), only one of which has identified nonsynonymous variation within the gene (Miller et al. 2005). Here, we describe the re-sequencing of a single gene, CRP, for the purpose of cataloguing both common and rare variation, and we also describe the possible application of the discovered variants in population-based survey using both "indirect" and "direct" association study designs. We demonstrate that while deep re-sequencing or re-sequencing in several racial/ethnic populations results in the identification of rare, potentially damaging nonsynonymous SNPs, the effort may not necessarily translate to a better understanding of the gene's impact on human phenotypes when applied to larger cohorts linked to quantitative phenotypes.
###end p 7
###begin title 8
Materials and methods
###end title 8
###begin title 9
Sequencing
###end title 9
###begin p 10
###xml 237 238 237 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 266 267 266 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 838 842 838 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">1998</xref>
As part of NHLBI's Program for Genomic Applications, SeattleSNPs re-sequences genes involved in inflammation, lipid metabolism, and blood pressure regulation for genetic variation discovery in two population samples: European-Americans (n=23) and African-Americans (n=24) obtained from Coriell Cell Repository. The European-American samples are members of the CEPH panel (NA12560, NA12547, NA10845, NA10853, NA10860, NA10830, NA10842, NA10851, NA07349, NA10857, NA10858, NA10848, NA12548, NA10844, NA10854, NA10861, NA10831, NA10843, NA10850, NA07348, NA10852, NA06990, NA07019) and the African-American samples are members of the African-American panel of 50 (NA17101-NA17116; NA17133-NA17140). Additional sequencing for variation discovery was performed on samples from the Polymorphism Discovery Resource Panel (PDR450)(Collins et al. 1998) and several other population samples obtained from Coriell Cell Repository, including seven Chinese (NA16654, NA16688-NA16689, NA17014-NA17017), seven Japanese (NA17051-NA17057), ten Southeast Asians (NA17081-NA17090), ten Mexicans (NA17061-NA17070), and six Indo-Pakistanis (NA17021-NA17024; NA17026-NA17027).
###end p 10
###begin p 11
###xml 57 60 57 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRP</italic>
###xml 196 204 196 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Sec11" ref-type="sec">Websites</xref>
###xml 246 249 246 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRP</italic>
All samples were re-sequenced for variation discovery in CRP on an ABI3730 using standard Big Dye terminator chemistry. A detailed laboratory protocol can be found on the SeattleSNPs website (see Websites). A total of 6.8 kb was re-sequenced for CRP, including all exons, all introns, 1.7 kb 5' flanking, and 2.8 kb 3' flanking. SNPs were numbered based on the GenBank accession number AF449713 and were submitted to dbSNP. The SNP number does not correspond with the translation start site. The location, rs number (where available), and sequence context of the SNPs described here can be found in Supplementary Table 1. All SNP allele frequencies and 95% confidence intervals for each population sample are given in Supplementary Table 2.
###end p 11
###begin p 12
###xml 60 64 60 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR32">2001</xref>
###xml 88 92 88 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR31">2003</xref>
###xml 320 321 320 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 321 322 321 322 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 344 348 344 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">2004</xref>
###xml 466 470 466 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR27">2002</xref>
###xml 498 502 498 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR24">2002</xref>
Haplotypes were inferred using PHASEv2.1.1 (Stephens et al. 2001; Stephens and Donnelly 2003) using SNPs with a minor allele frequency of >5%. Inferred haplotypes and their counts are given in Supplementary Table 3 for each population sample. TagSNPs were determined using LDSelect with a minor allele frequency >5% and r2>0.64 (Carlson et al. 2004). The predicted effects of all nonsynonymous variation were explored computationally using PolyPhen (Ramensky et al. 2002) and SIFT (Ng and Henikoff 2002).
###end p 12
###begin title 13
Genotyping
###end title 13
###begin p 14
###xml 15 18 15 16 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174;</sup>
###xml 35 38 33 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174;</sup>
###xml 96 99 92 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRP</italic>
###xml 155 158 151 152 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174;</sup>
Standard TaqMan(R) Assays by Design(R) were developed to genotype two sites newly discovered in CRP: 2513 and 2612. The sequence for the primers and Taqman(R) probes for 2513 was 5'-GATCGTGGAGTTCTGGGTAGATG-3' (forward), 5'-ACAGTGTATCCCTTCTTCAGACTCT-3' (reverse), 5'-CACCCTGGGCTTC-3' (C allele probe), and 5'-TCACCCTGAGCTTC-3' (T allele probe). For 2612, the primers and probes were 5'-GGGCAGGAGCAGGATTCC-3' (forward), 5'-AGTCCCACATGTTCACATTTCCAAT-3' (reverse), 5'-ACTTTGAAGGAAGCCAG-3' (G allele probe), and 5'-ACTTTGAAGAAAGCCAG-3' (A allele probe). The two assays were validated, and individuals identified as heterozygous for 2612 were confirmed by re-sequencing.
###end p 14
###begin p 15
###xml 13 14 13 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 135 138 135 136 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174;</sup>
###xml 667 675 665 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Sec11" ref-type="sec">Websites</xref>
###xml 761 762 759 760 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 792 793 790 791 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 825 826 823 824 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 862 863 860 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
DNA samples (n=7,296) from the National Health and Nutrition Examination Survey (NHANES) III were genotyped for the two sites by Taqman(R). The genotyping success rate was 97% for both SNPs. NHANES III is a population-based sample of Americans collected regardless of health status between 1988 and 1994, and DNA was collected for phase 2 of the survey (1991-1994). All DNA samples are linked to an extensive collection of laboratory phenotypes, such as serum CRP levels, as well as survey data. Survey design and ascertainment of NHANES III as well as descriptions of the phenotypic variables can be found at CDC's National Center for Health Statistics website (see Websites). The three largest racial/ethnic groups for NHANES III include non-Hispanic whites (n=2,630), non-Hispanic blacks (n=2,108), and Mexican-Americans (n=2,073). A small number of samples (n=137) were duplicates or not linked to the phenotypic data and were not included in subsequent analyses.
###end p 15
###begin title 16
Results
###end title 16
###begin title 17
SNP discovery
###end title 17
###begin p 18
###xml 78 81 78 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRP</italic>
###xml 226 227 226 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 255 256 255 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 308 309 308 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 323 324 323 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 345 346 345 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 362 363 362 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 390 391 390 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 496 497 496 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 555 559 555 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">1998</xref>
###xml 1001 1005 1001 1005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR21">2001</xref>
###xml 1089 1093 1089 1093 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR21">2001</xref>
Three sets of population samples were re-sequenced for variation discovery in CRP with different goals: (1) the standard SeattleSNPs population samples re-sequenced for mostly common variation discovery in European-Americans (n=23) and African-Americans (n=24); (2) an extended DNA panel of Asians (Chinese, n=7; Japanese, n=7, Southeast Asian, n=10), Mexicans (n=10), and Indo-Pakistanis (n=6) for population-specific variation discovery; and (3) the Polymorphism Discovery Resource Panel (PDR; n=450) for rare coding variation discovery (Collins et al. 1998). Both the SeattleSNPs and extended DNA panels have sufficient power to identify common SNPs (minor allele frequency >5%); however, the range of power depends on the number of chromosomes re-sequenced for each population sample. Thus, the African-American and combined Asian samples have the highest detection rate for common SNPs (99%), and the Indo-Pakistani sample has the lowest detect rate for common SNPs (>80%)(Kruglyak and Nickerson 2001). The PDR can detect 99% of SNPs with a MAF of at least 1% (Kruglyak and Nickerson 2001).
###end p 18
###begin p 19
###xml 50 53 50 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRP</italic>
###xml 387 388 387 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 399 400 399 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 621 622 621 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 815 816 815 816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 1210 1216 1210 1216 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;1</label>
###xml 1216 1219 1216 1219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRP</italic>
###xml 1271 1272 1271 1272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1302 1303 1302 1303 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1468 1474 1468 1474 <italic xmlns:xlink="http://www.w3.org/1999/xlink">square</italic>
###xml 1548 1552 1548 1552 <italic xmlns:xlink="http://www.w3.org/1999/xlink">blue</italic>
###xml 1569 1572 1569 1572 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 1596 1602 1596 1602 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yellow</italic>
###xml 1605 1609 1605 1609 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gray</italic>
###xml 1635 1648 1635 1648 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Abbreviations</italic>
###xml 1668 1669 1668 1669 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1691 1692 1691 1692 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 1715 1721 1715 1721 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V31-36</italic>
###xml 1739 1745 1739 1745 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V80-89</italic>
###xml 1760 1786 1760 1786 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V71-77, V130-139, V321-327</italic>
###xml 1216 1794 1216 1794 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="20"><italic>CRP</italic> variants identified re-sequencing the SeattleSNPs (<italic>n</italic>=47) and extended DNA panels (<italic>n</italic>=40). SNPs are numbered across the top of the figure in order of discovery in the reference sequence. Individual samples are labeled to the left of the figure. Each <italic>square</italic> represents the genotype of a SNP for each individual: homozygous common (<italic>blue</italic>), heterozygous (<italic>red</italic>), and homozygous rare (<italic>yellow</italic>). <italic>Gray</italic> represents missing data. <italic>Abbreviations</italic>: African-American (<italic>D</italic>), European-American (<italic>E</italic>), extended panel DNA (<italic>V31-36</italic>: Indo-Pakistani, <italic>V80-89</italic>: Mexican; and <italic>V71-77, V130-139, V321-327</italic>: Asian)</p>
###xml 1216 1794 1216 1794 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="20"><italic>CRP</italic> variants identified re-sequencing the SeattleSNPs (<italic>n</italic>=47) and extended DNA panels (<italic>n</italic>=40). SNPs are numbered across the top of the figure in order of discovery in the reference sequence. Individual samples are labeled to the left of the figure. Each <italic>square</italic> represents the genotype of a SNP for each individual: homozygous common (<italic>blue</italic>), heterozygous (<italic>red</italic>), and homozygous rare (<italic>yellow</italic>). <italic>Gray</italic> represents missing data. <italic>Abbreviations</italic>: African-American (<italic>D</italic>), European-American (<italic>E</italic>), extended panel DNA (<italic>V31-36</italic>: Indo-Pakistani, <italic>V80-89</italic>: Mexican; and <italic>V71-77, V130-139, V321-327</italic>: Asian)</p></caption>
###xml 1794 1794 1794 1794 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="439_2006_160_Fig1_HTML" id="MO1"/>
###xml 1210 1794 1210 1794 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig1"><label>Fig.&#160;1</label><caption><p textid="20"><italic>CRP</italic> variants identified re-sequencing the SeattleSNPs (<italic>n</italic>=47) and extended DNA panels (<italic>n</italic>=40). SNPs are numbered across the top of the figure in order of discovery in the reference sequence. Individual samples are labeled to the left of the figure. Each <italic>square</italic> represents the genotype of a SNP for each individual: homozygous common (<italic>blue</italic>), heterozygous (<italic>red</italic>), and homozygous rare (<italic>yellow</italic>). <italic>Gray</italic> represents missing data. <italic>Abbreviations</italic>: African-American (<italic>D</italic>), European-American (<italic>E</italic>), extended panel DNA (<italic>V31-36</italic>: Indo-Pakistani, <italic>V80-89</italic>: Mexican; and <italic>V71-77, V130-139, V321-327</italic>: Asian)</p></caption><graphic position="anchor" xlink:href="439_2006_160_Fig1_HTML" id="MO1"/></fig>
###xml 1794 1801 1794 1801 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;1</label>
###xml 1857 1858 1857 1858 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 1883 1888 1883 1884 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#952;</italic>
###xml 1929 1932 1925 1928 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRP</italic>
###xml 1801 1964 1801 1960 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="21">Sample size (chromosomes), number of segregating sites (<italic>S</italic>), nucleotide diversity (<italic>&#952;</italic>), and number of inferred haplotypes for <italic>CRP</italic> re-sequenced in several samples</p>
###xml 1801 1964 1801 1960 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="21">Sample size (chromosomes), number of segregating sites (<italic>S</italic>), nucleotide diversity (<italic>&#952;</italic>), and number of inferred haplotypes for <italic>CRP</italic> re-sequenced in several samples</p></caption>
###xml 1964 1970 1960 1966 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Sample</th>
###xml 1970 1971 1966 1967 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 1970 1971 1966 1967 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>N</italic></th>
###xml 1971 1972 1967 1968 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 1971 1981 1967 1977 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>S</italic> (MAF&gt;5%)</th>
###xml 1981 1986 1977 1978 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#952;</italic>
###xml 1990 1992 1982 1984 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;4</sup>
###xml 1981 1993 1977 1985 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>&#952;</italic> (10<sup>&#8722;4</sup>)</th>
###xml 1993 2020 1985 2012 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Haplotypes (heterozygosity)</th>
###xml 1964 2020 1960 2012 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left">Sample</th><th align="left"><italic>N</italic></th><th align="left"><italic>S</italic> (MAF&gt;5%)</th><th align="left"><italic>&#952;</italic> (10<sup>&#8722;4</sup>)</th><th align="left">Haplotypes (heterozygosity)</th></tr>
###xml 1964 2020 1960 2012 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th align="left">Sample</th><th align="left"><italic>N</italic></th><th align="left"><italic>S</italic> (MAF&gt;5%)</th><th align="left"><italic>&#952;</italic> (10<sup>&#8722;4</sup>)</th><th align="left">Haplotypes (heterozygosity)</th></tr></thead>
###xml 2020 2037 2012 2029 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">African-Americans</td>
###xml 2037 2039 2029 2031 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">48</td>
###xml 2039 2046 2031 2038 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">30 (18)</td>
###xml 2046 2051 2038 2043 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">11.96</td>
###xml 2051 2060 2043 2052 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">18 (0.86)</td>
###xml 2020 2060 2012 2052 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">African-Americans</td><td char="." align="char">48</td><td char="(" align="char">30 (18)</td><td char="." align="char">11.96</td><td char="(" align="char">18 (0.86)</td></tr>
###xml 2060 2078 2052 2070 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">European-Americans</td>
###xml 2078 2080 2070 2072 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">46</td>
###xml 2080 2087 2072 2079 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">13 (10)</td>
###xml 2087 2091 2079 2083 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">5.25</td>
###xml 2091 2099 2083 2091 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">7 (0.76)</td>
###xml 2060 2099 2052 2091 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">European-Americans</td><td char="." align="char">46</td><td char="(" align="char">13 (10)</td><td char="." align="char">5.25</td><td char="(" align="char">7 (0.76)</td></tr>
###xml 2099 2105 2091 2097 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Asians</td>
###xml 2105 2107 2097 2099 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">48</td>
###xml 2107 2113 2099 2105 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">17 (9)</td>
###xml 2113 2117 2105 2109 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">6.84</td>
###xml 2117 2126 2109 2118 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">11 (0.67)</td>
###xml 2099 2126 2091 2118 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Asians</td><td char="." align="char">48</td><td char="(" align="char">17 (9)</td><td char="." align="char">6.84</td><td char="(" align="char">11 (0.67)</td></tr>
###xml 2126 2134 2118 2126 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Mexicans</td>
###xml 2134 2136 2126 2128 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">20</td>
###xml 2136 2143 2128 2135 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">13 (11)</td>
###xml 2143 2147 2135 2139 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">6.32</td>
###xml 2147 2155 2139 2147 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">6 (0.74)</td>
###xml 2126 2155 2118 2147 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Mexicans</td><td char="." align="char">20</td><td char="(" align="char">13 (11)</td><td char="." align="char">6.32</td><td char="(" align="char">6 (0.74)</td></tr>
###xml 2155 2170 2147 2162 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Indo-Pakistanis</td>
###xml 2170 2172 2162 2164 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">12</td>
###xml 2172 2179 2164 2171 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">11 (11)</td>
###xml 2179 2183 2171 2175 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">7.17</td>
###xml 2183 2191 2175 2183 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">6 (0.75)</td>
###xml 2155 2191 2147 2183 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Indo-Pakistanis</td><td char="." align="char">12</td><td char="(" align="char">11 (11)</td><td char="." align="char">7.17</td><td char="(" align="char">6 (0.75)</td></tr>
###xml 2191 2196 2183 2188 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Total</td>
###xml 2196 2199 2188 2191 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">174</td>
###xml 2199 2206 2191 2198 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">40 (17)</td>
###xml 2206 2211 2198 2203 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">11.83</td>
###xml 2211 2220 2203 2212 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">29 (0.86)</td>
###xml 2191 2220 2183 2212 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Total</td><td char="." align="char">174</td><td char="(" align="char">40 (17)</td><td char="." align="char">11.83</td><td char="(" align="char">29 (0.86)</td></tr>
###xml 2020 2220 2012 2212 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td align="left">African-Americans</td><td char="." align="char">48</td><td char="(" align="char">30 (18)</td><td char="." align="char">11.96</td><td char="(" align="char">18 (0.86)</td></tr><tr><td align="left">European-Americans</td><td char="." align="char">46</td><td char="(" align="char">13 (10)</td><td char="." align="char">5.25</td><td char="(" align="char">7 (0.76)</td></tr><tr><td align="left">Asians</td><td char="." align="char">48</td><td char="(" align="char">17 (9)</td><td char="." align="char">6.84</td><td char="(" align="char">11 (0.67)</td></tr><tr><td align="left">Mexicans</td><td char="." align="char">20</td><td char="(" align="char">13 (11)</td><td char="." align="char">6.32</td><td char="(" align="char">6 (0.74)</td></tr><tr><td align="left">Indo-Pakistanis</td><td char="." align="char">12</td><td char="(" align="char">11 (11)</td><td char="." align="char">7.17</td><td char="(" align="char">6 (0.75)</td></tr><tr><td align="left">Total</td><td char="." align="char">174</td><td char="(" align="char">40 (17)</td><td char="." align="char">11.83</td><td char="(" align="char">29 (0.86)</td></tr></tbody>
###xml 1964 2220 1960 2212 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th align="left">Sample</th><th align="left"><italic>N</italic></th><th align="left"><italic>S</italic> (MAF&gt;5%)</th><th align="left"><italic>&#952;</italic> (10<sup>&#8722;4</sup>)</th><th align="left">Haplotypes (heterozygosity)</th></tr></thead><tbody><tr><td align="left">African-Americans</td><td char="." align="char">48</td><td char="(" align="char">30 (18)</td><td char="." align="char">11.96</td><td char="(" align="char">18 (0.86)</td></tr><tr><td align="left">European-Americans</td><td char="." align="char">46</td><td char="(" align="char">13 (10)</td><td char="." align="char">5.25</td><td char="(" align="char">7 (0.76)</td></tr><tr><td align="left">Asians</td><td char="." align="char">48</td><td char="(" align="char">17 (9)</td><td char="." align="char">6.84</td><td char="(" align="char">11 (0.67)</td></tr><tr><td align="left">Mexicans</td><td char="." align="char">20</td><td char="(" align="char">13 (11)</td><td char="." align="char">6.32</td><td char="(" align="char">6 (0.74)</td></tr><tr><td align="left">Indo-Pakistanis</td><td char="." align="char">12</td><td char="(" align="char">11 (11)</td><td char="." align="char">7.17</td><td char="(" align="char">6 (0.75)</td></tr><tr><td align="left">Total</td><td char="." align="char">174</td><td char="(" align="char">40 (17)</td><td char="." align="char">11.83</td><td char="(" align="char">29 (0.86)</td></tr></tbody></table>
###xml 1794 2220 1794 2212 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab1"><label>Table&#160;1</label><caption><p textid="21">Sample size (chromosomes), number of segregating sites (<italic>S</italic>), nucleotide diversity (<italic>&#952;</italic>), and number of inferred haplotypes for <italic>CRP</italic> re-sequenced in several samples</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Sample</th><th align="left"><italic>N</italic></th><th align="left"><italic>S</italic> (MAF&gt;5%)</th><th align="left"><italic>&#952;</italic> (10<sup>&#8722;4</sup>)</th><th align="left">Haplotypes (heterozygosity)</th></tr></thead><tbody><tr><td align="left">African-Americans</td><td char="." align="char">48</td><td char="(" align="char">30 (18)</td><td char="." align="char">11.96</td><td char="(" align="char">18 (0.86)</td></tr><tr><td align="left">European-Americans</td><td char="." align="char">46</td><td char="(" align="char">13 (10)</td><td char="." align="char">5.25</td><td char="(" align="char">7 (0.76)</td></tr><tr><td align="left">Asians</td><td char="." align="char">48</td><td char="(" align="char">17 (9)</td><td char="." align="char">6.84</td><td char="(" align="char">11 (0.67)</td></tr><tr><td align="left">Mexicans</td><td char="." align="char">20</td><td char="(" align="char">13 (11)</td><td char="." align="char">6.32</td><td char="(" align="char">6 (0.74)</td></tr><tr><td align="left">Indo-Pakistanis</td><td char="." align="char">12</td><td char="(" align="char">11 (11)</td><td char="." align="char">7.17</td><td char="(" align="char">6 (0.75)</td></tr><tr><td align="left">Total</td><td char="." align="char">174</td><td char="(" align="char">40 (17)</td><td char="." align="char">11.83</td><td char="(" align="char">29 (0.86)</td></tr></tbody></table></table-wrap>
To determine whether SeattleSNPs is capturing all CRP common variation found in many populations by re-sequencing only European- and African-American samples, we compared the SNPs identified by the usual SeattleSNPs DNA panel to the extended DNA panel containing samples of Asian, Mexican, and Indo-Pakistani ancestry. From these two DNA panels, a total of 40 SNPs were identified (Fig. 1 and Table 1). As expected, a greater number of SNPs was identified in the African-American population sample (30) compared with the Asian (17), Mexican (13), European-American (13), and Indo-Pakistani (11) population samples (Table 1). Also, an increase in nucleotide diversity as well as a greater number of haplotypes was observed in the African-American population samples compared with the other population samples (Table 1). Approximately half (58%) of the 40 SNPs are private to one population sample, most of which were found in the African-American population sample (14 SNPs). The inclusion of the extended DNA panel allowed the identification of nine SNPs not identified in the SeattleSNPs panel. Two of the nine new sites were common (>5% MAF) within the Indo-Pakistani population sample (sites 974 and 2513). Fig. 1CRP variants identified re-sequencing the SeattleSNPs (n=47) and extended DNA panels (n=40). SNPs are numbered across the top of the figure in order of discovery in the reference sequence. Individual samples are labeled to the left of the figure. Each square represents the genotype of a SNP for each individual: homozygous common (blue), heterozygous (red), and homozygous rare (yellow). Gray represents missing data. Abbreviations: African-American (D), European-American (E), extended panel DNA (V31-36: Indo-Pakistani, V80-89: Mexican; and V71-77, V130-139, V321-327: Asian)Table 1Sample size (chromosomes), number of segregating sites (S), nucleotide diversity (theta), and number of inferred haplotypes for CRP re-sequenced in several samplesSampleNS (MAF>5%)theta (10-4)Haplotypes (heterozygosity)African-Americans4830 (18)11.9618 (0.86)European-Americans4613 (10)5.257 (0.76)Asians4817 (9)6.8411 (0.67)Mexicans2013 (11)6.326 (0.74)Indo-Pakistanis1211 (11)7.176 (0.75)Total17440 (17)11.8329 (0.86)
###end p 19
###begin p 20
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRP</italic>
###xml 55 56 55 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 86 87 86 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 252 258 252 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">square</italic>
###xml 332 336 332 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">blue</italic>
###xml 353 356 353 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 380 386 380 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yellow</italic>
###xml 389 393 389 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gray</italic>
###xml 419 432 419 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Abbreviations</italic>
###xml 452 453 452 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 475 476 475 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 499 505 499 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V31-36</italic>
###xml 523 529 523 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V80-89</italic>
###xml 544 570 544 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V71-77, V130-139, V321-327</italic>
CRP variants identified re-sequencing the SeattleSNPs (n=47) and extended DNA panels (n=40). SNPs are numbered across the top of the figure in order of discovery in the reference sequence. Individual samples are labeled to the left of the figure. Each square represents the genotype of a SNP for each individual: homozygous common (blue), heterozygous (red), and homozygous rare (yellow). Gray represents missing data. Abbreviations: African-American (D), European-American (E), extended panel DNA (V31-36: Indo-Pakistani, V80-89: Mexican; and V71-77, V130-139, V321-327: Asian)
###end p 20
###begin p 21
###xml 56 57 56 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 82 87 82 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#952;</italic>
###xml 128 131 124 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRP</italic>
Sample size (chromosomes), number of segregating sites (S), nucleotide diversity (theta), and number of inferred haplotypes for CRP re-sequenced in several samples
###end p 21
###begin p 22
###xml 32 35 32 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRP</italic>
Among the 40 SNPs identified in CRP, one unique variant is the high frequency triallelic SNP 1440 (rs3091244). All three alleles of 1440, A, C, and T, occur with appreciable frequency in the African-American (0.33, 0.26, and 0.41) and European-American (0.05, 0.62, and 0.33) population samples. Examination of the extended DNA panel reveals that the combined Asian population sample of Chinese, Japanese, and Southeast Asian samples is also polymorphic for all three 1440 alleles (0.19, 0.75, and 0.06); however, the allele frequency distribution in the combined Asian population sample is very different compared with the African- and European-American population samples. The Mexican population sample does not contain all three alleles, possibly due to the smaller sample size of this collection compared with the other three population samples. Among chromosomes of Mexican-descent, the C allele occurs more frequently (0.75) than the T allele. Finally, among the Indo-Pakistani samples, the C allele is predominant over the A allele (0.83 vs. 0.17). Again, the absence of the third allele (T) may be due to the small sample size of this population collection compared with the larger collections.
###end p 22
###begin title 23
Coding variation
###end title 23
###begin p 24
###xml 127 130 127 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRP</italic>
###xml 224 225 224 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab2" ref-type="table">2</xref>
###xml 367 368 367 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab2" ref-type="table">2</xref>
###xml 372 379 372 379 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;2</label>
###xml 379 382 379 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRP</italic>
###xml 379 423 379 423 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="25"><italic>CRP</italic> variants identified in the coding region</p>
###xml 379 423 379 423 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="25"><italic>CRP</italic> variants identified in the coding region</p></caption>
###xml 423 427 423 427 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Site</th>
###xml 427 444 427 444 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Nucleotide change</th>
###xml 444 472 444 472 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Amino acid change (position)</th>
###xml 472 501 472 501 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Number of chromosomes (panel)</th>
###xml 501 525 501 525 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">SIFT/PolyPhen prediction</th>
###xml 423 525 423 525 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left">Site</th><th align="left">Nucleotide change</th><th align="left">Amino acid change (position)</th><th align="left">Number of chromosomes (panel)</th><th align="left">SIFT/PolyPhen prediction</th></tr>
###xml 423 525 423 525 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th align="left">Site</th><th align="left">Nucleotide change</th><th align="left">Amino acid change (position)</th><th align="left">Number of chromosomes (panel)</th><th align="left">SIFT/PolyPhen prediction</th></tr></thead>
###xml 525 542 525 542 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="5">(a) Nonsynonymous</td>
###xml 525 542 525 542 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" colspan="5">(a) Nonsynonymous</td></tr>
###xml 542 547 542 547 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;2314</td>
###xml 547 552 547 552 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">T&#160;&gt;&#160;C</td>
###xml 552 567 552 567 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Tyr to His (67)</td>
###xml 567 578 567 578 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1/794 (PDR)</td>
###xml 578 594 578 594 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Tolerated/benign</td>
###xml 542 594 542 594 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;2314</td><td align="left">T&#160;&gt;&#160;C</td><td align="left">Tyr to His (67)</td><td align="left">1/794 (PDR)</td><td align="left">Tolerated/benign</td></tr>
###xml 594 599 594 599 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;2513</td>
###xml 599 604 599 604 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">C&#160;&gt;&#160;T</td>
###xml 604 620 604 620 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Pro to Lys (133)</td>
###xml 620 635 620 635 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1/80 (extended)</td>
###xml 635 662 635 662 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Tolerated/possibly damaging</td>
###xml 594 662 594 662 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;2513</td><td align="left">C&#160;&gt;&#160;T</td><td align="left">Pro to Lys (133)</td><td align="left">1/80 (extended)</td><td align="left">Tolerated/possibly damaging</td></tr>
###xml 662 667 662 667 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;2612</td>
###xml 667 672 667 672 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">G&#160;&gt;&#160;A</td>
###xml 672 688 672 688 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Gly to Glu (166)</td>
###xml 688 699 688 699 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1/828 (PDR)</td>
###xml 699 726 699 726 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Tolerated/possibly damaging</td>
###xml 662 726 662 726 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;2612</td><td align="left">G&#160;&gt;&#160;A</td><td align="left">Gly to Glu (166)</td><td align="left">1/828 (PDR)</td><td align="left">Tolerated/possibly damaging</td></tr>
###xml 726 740 726 740 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="5">(b) Synonymous</td>
###xml 726 740 726 740 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" colspan="5">(b) Synonymous</td></tr>
###xml 740 745 740 745 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;2220</td>
###xml 745 750 745 750 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">T&#160;&gt;&#160;G</td>
###xml 750 765 750 765 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Thr to Thr (35)</td>
###xml 765 776 765 776 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">7/700 (PDR)</td>
###xml 776 779 776 779 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">N/A</td>
###xml 740 779 740 779 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;2220</td><td align="left">T&#160;&gt;&#160;G</td><td align="left">Thr to Thr (35)</td><td align="left">7/700 (PDR)</td><td align="left">N/A</td></tr>
###xml 779 784 779 784 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;2244</td>
###xml 784 789 784 789 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">G&#160;&gt;&#160;A</td>
###xml 789 804 789 804 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Pro to Pro (43)</td>
###xml 804 815 804 815 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">3/734 (PDR)</td>
###xml 815 818 815 818 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">N/A</td>
###xml 779 818 779 818 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;2244</td><td align="left">G&#160;&gt;&#160;A</td><td align="left">Pro to Pro (43)</td><td align="left">3/734 (PDR)</td><td align="left">N/A</td></tr>
###xml 818 823 818 823 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;2475</td>
###xml 823 828 823 828 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">C&#160;&gt;&#160;T</td>
###xml 828 844 828 844 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Ser to Ser (120)</td>
###xml 844 859 844 859 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">2/80 (extended)</td>
###xml 859 862 859 862 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">N/A</td>
###xml 818 862 818 862 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;2475</td><td align="left">C&#160;&gt;&#160;T</td><td align="left">Ser to Ser (120)</td><td align="left">2/80 (extended)</td><td align="left">N/A</td></tr>
###xml 862 879 862 879 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;2667 (rs1800947)</td>
###xml 879 884 879 884 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">G&#160;&gt;&#160;C</td>
###xml 884 900 884 900 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Leu to Leu (184)</td>
###xml 900 912 900 912 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">36/826 (PDR)</td>
###xml 912 915 912 915 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">N/A</td>
###xml 862 915 862 915 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;2667 (rs1800947)</td><td align="left">G&#160;&gt;&#160;C</td><td align="left">Leu to Leu (184)</td><td align="left">36/826 (PDR)</td><td align="left">N/A</td></tr>
###xml 525 915 525 915 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td align="left" colspan="5">(a) Nonsynonymous</td></tr><tr><td align="left">&#160;2314</td><td align="left">T&#160;&gt;&#160;C</td><td align="left">Tyr to His (67)</td><td align="left">1/794 (PDR)</td><td align="left">Tolerated/benign</td></tr><tr><td align="left">&#160;2513</td><td align="left">C&#160;&gt;&#160;T</td><td align="left">Pro to Lys (133)</td><td align="left">1/80 (extended)</td><td align="left">Tolerated/possibly damaging</td></tr><tr><td align="left">&#160;2612</td><td align="left">G&#160;&gt;&#160;A</td><td align="left">Gly to Glu (166)</td><td align="left">1/828 (PDR)</td><td align="left">Tolerated/possibly damaging</td></tr><tr><td align="left" colspan="5">(b) Synonymous</td></tr><tr><td align="left">&#160;2220</td><td align="left">T&#160;&gt;&#160;G</td><td align="left">Thr to Thr (35)</td><td align="left">7/700 (PDR)</td><td align="left">N/A</td></tr><tr><td align="left">&#160;2244</td><td align="left">G&#160;&gt;&#160;A</td><td align="left">Pro to Pro (43)</td><td align="left">3/734 (PDR)</td><td align="left">N/A</td></tr><tr><td align="left">&#160;2475</td><td align="left">C&#160;&gt;&#160;T</td><td align="left">Ser to Ser (120)</td><td align="left">2/80 (extended)</td><td align="left">N/A</td></tr><tr><td align="left">&#160;2667 (rs1800947)</td><td align="left">G&#160;&gt;&#160;C</td><td align="left">Leu to Leu (184)</td><td align="left">36/826 (PDR)</td><td align="left">N/A</td></tr></tbody>
###xml 423 915 423 915 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th align="left">Site</th><th align="left">Nucleotide change</th><th align="left">Amino acid change (position)</th><th align="left">Number of chromosomes (panel)</th><th align="left">SIFT/PolyPhen prediction</th></tr></thead><tbody><tr><td align="left" colspan="5">(a) Nonsynonymous</td></tr><tr><td align="left">&#160;2314</td><td align="left">T&#160;&gt;&#160;C</td><td align="left">Tyr to His (67)</td><td align="left">1/794 (PDR)</td><td align="left">Tolerated/benign</td></tr><tr><td align="left">&#160;2513</td><td align="left">C&#160;&gt;&#160;T</td><td align="left">Pro to Lys (133)</td><td align="left">1/80 (extended)</td><td align="left">Tolerated/possibly damaging</td></tr><tr><td align="left">&#160;2612</td><td align="left">G&#160;&gt;&#160;A</td><td align="left">Gly to Glu (166)</td><td align="left">1/828 (PDR)</td><td align="left">Tolerated/possibly damaging</td></tr><tr><td align="left" colspan="5">(b) Synonymous</td></tr><tr><td align="left">&#160;2220</td><td align="left">T&#160;&gt;&#160;G</td><td align="left">Thr to Thr (35)</td><td align="left">7/700 (PDR)</td><td align="left">N/A</td></tr><tr><td align="left">&#160;2244</td><td align="left">G&#160;&gt;&#160;A</td><td align="left">Pro to Pro (43)</td><td align="left">3/734 (PDR)</td><td align="left">N/A</td></tr><tr><td align="left">&#160;2475</td><td align="left">C&#160;&gt;&#160;T</td><td align="left">Ser to Ser (120)</td><td align="left">2/80 (extended)</td><td align="left">N/A</td></tr><tr><td align="left">&#160;2667 (rs1800947)</td><td align="left">G&#160;&gt;&#160;C</td><td align="left">Leu to Leu (184)</td><td align="left">36/826 (PDR)</td><td align="left">N/A</td></tr></tbody></table>
###xml 915 918 915 918 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDR</italic>
###xml 915 956 915 956 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="26"><italic>PDR</italic> Polymorphism Discovery Resource panel</p>
###xml 915 956 915 956 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="26"><italic>PDR</italic> Polymorphism Discovery Resource panel</p></table-wrap-foot>
###xml 372 956 372 956 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab2"><label>Table&#160;2</label><caption><p textid="25"><italic>CRP</italic> variants identified in the coding region</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Site</th><th align="left">Nucleotide change</th><th align="left">Amino acid change (position)</th><th align="left">Number of chromosomes (panel)</th><th align="left">SIFT/PolyPhen prediction</th></tr></thead><tbody><tr><td align="left" colspan="5">(a) Nonsynonymous</td></tr><tr><td align="left">&#160;2314</td><td align="left">T&#160;&gt;&#160;C</td><td align="left">Tyr to His (67)</td><td align="left">1/794 (PDR)</td><td align="left">Tolerated/benign</td></tr><tr><td align="left">&#160;2513</td><td align="left">C&#160;&gt;&#160;T</td><td align="left">Pro to Lys (133)</td><td align="left">1/80 (extended)</td><td align="left">Tolerated/possibly damaging</td></tr><tr><td align="left">&#160;2612</td><td align="left">G&#160;&gt;&#160;A</td><td align="left">Gly to Glu (166)</td><td align="left">1/828 (PDR)</td><td align="left">Tolerated/possibly damaging</td></tr><tr><td align="left" colspan="5">(b) Synonymous</td></tr><tr><td align="left">&#160;2220</td><td align="left">T&#160;&gt;&#160;G</td><td align="left">Thr to Thr (35)</td><td align="left">7/700 (PDR)</td><td align="left">N/A</td></tr><tr><td align="left">&#160;2244</td><td align="left">G&#160;&gt;&#160;A</td><td align="left">Pro to Pro (43)</td><td align="left">3/734 (PDR)</td><td align="left">N/A</td></tr><tr><td align="left">&#160;2475</td><td align="left">C&#160;&gt;&#160;T</td><td align="left">Ser to Ser (120)</td><td align="left">2/80 (extended)</td><td align="left">N/A</td></tr><tr><td align="left">&#160;2667 (rs1800947)</td><td align="left">G&#160;&gt;&#160;C</td><td align="left">Leu to Leu (184)</td><td align="left">36/826 (PDR)</td><td align="left">N/A</td></tr></tbody></table><table-wrap-foot><p textid="26"><italic>PDR</italic> Polymorphism Discovery Resource panel</p></table-wrap-foot></table-wrap>
One of the sites identified in the Indo-Pakistani sample, SNP 2513 (MAF=0.08), is a nonsynonymous SNP (Pro133Lys) in exon 2 of CRP. Site 2513 is predicted to be "possibly damaging" by PolyPhen but "tolerated" by SIFT (Table 2a). Also, site 2475 identified in two heterozygous individuals from the Japanese population sample is a novel synonymous SNP in exon 2 (Table 2a). Table 2CRP variants identified in the coding regionSiteNucleotide changeAmino acid change (position)Number of chromosomes (panel)SIFT/PolyPhen prediction(a) Nonsynonymous 2314T > CTyr to His (67)1/794 (PDR)Tolerated/benign 2513C > TPro to Lys (133)1/80 (extended)Tolerated/possibly damaging 2612G > AGly to Glu (166)1/828 (PDR)Tolerated/possibly damaging(b) Synonymous 2220T > GThr to Thr (35)7/700 (PDR)N/A 2244G > APro to Pro (43)3/734 (PDR)N/A 2475C > TSer to Ser (120)2/80 (extended)N/A 2667 (rs1800947)G > CLeu to Leu (184)36/826 (PDR)N/APDR Polymorphism Discovery Resource panel
###end p 24
###begin p 25
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRP</italic>
CRP variants identified in the coding region
###end p 25
###begin p 26
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDR</italic>
PDR Polymorphism Discovery Resource panel
###end p 26
###begin p 27
###xml 27 30 27 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRP</italic>
###xml 141 144 141 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRP</italic>
###xml 984 985 984 985 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab2" ref-type="table">2</xref>
###xml 1121 1122 1121 1122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab2" ref-type="table">2</xref>
###xml 1540 1544 1540 1544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR23">2005</xref>
Given the possibility that CRP contains previously unidentified rare and potentially population-specific nonsynonymous SNPs, we re-sequenced CRP in individuals from the Polymorphism Discovery Resource Panel (PDR450) primarily to discover novel coding variation. The PDR450 samples are not linked to racial/ethnic identifiers; therefore, the panel is useful for DNA variation discovery, but not for allele frequency estimation for specific populations. Overall, 46 sites were identified in the PDR, 61% of which were not found among the SeattleSNPs and extended DNA panel samples. All novel sites in the PDR had a minor allele frequency of 2% or less (Supplementary Table 2). Among these novel sites, we identified two additional nonsynonymous SNPs, sites 2314 (Tyr67His) and 2612 (Gly166Glu), each in a single heterozygous individual. Site 2314 is predicted to be tolerated/benign and site 2612 is predicted to be tolerated/possibly damaging by SIFT and PolyPhen, respectively (Table 2a). A previously described (site 2667) as well as two novel synonymous SNPs (sites 2220 and 2244) was also identified in the PDR (Table 2b). Not surprisingly, the synonymous sites, unlike the nonsynonymous sites, were identified in more than one individual. The nonsynonymous site 2513 and the synonymous site 2475 identified in the Indo-Pakistani and Japanese samples, respectively, were not identified in the larger PDR sample. We could not confirm the recently reported nonsynonymous Thr45Met in any of the populations re-sequenced here (Miller et al. 2005).
###end p 27
###begin p 28
###xml 261 265 261 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">2003</xref>
The newly identified nonsynonymous SNPs are of obvious interest to investigators designing direct genetic association studies because it is assumed that these SNPs are more likely to have a direct impact on the phenotype than noncoding SNPs (Botstein and Risch 2003). However, nonsynonymous SNPs are only informative if they occur at an appreciable frequency in the general population or are enriched among individuals with specific diseases/outcomes. To better characterize the allele and genotype frequency of the possibly damaging nonsynonymous SNPs in a general population, we genotyped sites 2513 and 2612 in a sample of 7,296 DNAs collected by the Centers for Disease Control and Prevention for phase 2 of the National Health and Nutrition Examination Survey (NHANES) III. In >14,000 chromosomes examined, no individual was heterozygous for site 2513. For site 2612, we identified two heterozygous individuals. Thus, these two sites are rare in the general population with a minor allele frequency well below 1%.
###end p 28
###begin title 29
CRP and dbSNP
###end title 29
###begin p 30
###xml 326 330 326 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">2003</xref>
###xml 345 349 345 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR19">2003</xref>
###xml 364 368 364 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR28">2003</xref>
###xml 570 574 570 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">2003</xref>
###xml 589 593 589 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR19">2003</xref>
###xml 624 627 624 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRP</italic>
###xml 726 729 726 729 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRP</italic>
For both direct and indirect association study designs, one common concern for investigators is the reliance on public databases for available genetic variations in the gene or region of interest. Previous work examining the quality and completeness of dbSNP suggests that >50% of the reported SNPs are common (Carlson et al. 2003; Jiang et al. 2003; Reich et al. 2003). These studies also demonstrate that a considerable fraction of SNPs in dbSNP (~40%) cannot be found in other samples, suggesting these reported SNPs are either very rare or artifacts (Carlson et al. 2003; Jiang et al. 2003). To examine these issues for CRP, we mapped the SNPs identified here by deep re-sequencing to those found within dbSNP in the gene CRP.
###end p 30
###begin p 31
###xml 67 70 67 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRP</italic>
###xml 694 697 694 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRP</italic>
###xml 930 933 930 933 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRP</italic>
For build 125 of dbSNP, 17 DNA variations are reported in the gene CRP. Five of the 17 DNA variations reported by dbSNP are considered validated SNPs. To directly compare SNPs reported in dbSNP to the SNPs discovered in the various populations reported here, we only considered the 21 SNPs we annotated in exons 1 and 2 and intron 1. Only six of the 17 dbSNP reports (35%) can be confirmed by the re-sequencing efforts described here, and all six of these SNPs were common SNPs reported by SeattleSNPs. These six SNPs included the five validated SNPs. More than half of the dbSNP submissions (11/17; 64.7%) cannot be confirmed by any of the populations re-sequenced here. Overall, 71.4% of the CRP variants identified here are not currently found in dbSNP; however, none of these SNPs is common among the chromosomes re-sequenced here. Thus, dbSNP is most likely complete for common variation but incomplete for rare variation in CRP, as expected.
###end p 31
###begin title 32
TagSNPs for association studies
###end title 32
###begin p 33
###xml 394 398 394 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">2004</xref>
###xml 406 410 406 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR33">2004</xref>
###xml 552 556 552 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR41">2004</xref>
Another common concern for investigators is that an optimal subset of SNPs (termed "tagSNPs") must be chosen from the information at hand for genotyping in a genetic association study. The tagSNP or "indirect" approach can be an economical approach because only SNPs that maintain the genetic diversity of the gene or region (as defined by linkage disequilibrium) are genotyped (Carlson et al. 2004; Stram 2004). Recent evidence suggests that tagSNPs are transferable across populations of similar race/ethnicity without loss of information (Ke et al. 2004). SeattleSNPs routinely chooses tagSNPs for European-American and African-American population samples, and it is expected that these tagSNPs will be sufficient for association studies genotyping samples of European- and African-descent. However, it is not know how well these tagSNPs perform when genotyped in an admixed population such as Mexican-Americans.
###end p 33
###begin p 34
###xml 230 234 230 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR37">1991</xref>
###xml 248 252 248 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR38">1991</xref>
###xml 277 281 277 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR40">2004</xref>
###xml 297 301 297 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR39">2005</xref>
###xml 539 540 539 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 606 607 606 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 639 640 639 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 640 641 640 641 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 1076 1079 1076 1079 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRP</italic>
###xml 1166 1167 1166 1167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 1171 1177 1171 1177 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;2</label>
###xml 1282 1283 1282 1283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 1283 1284 1283 1284 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 1177 1289 1177 1289 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="35">TagSNPs chosen for four population samples. TagSNPs were chosen from SNPs with MAF &gt;5% using LDSelect at <italic>r</italic><sup>2</sup>&gt;0.64</p>
###xml 1177 1289 1177 1289 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="35">TagSNPs chosen for four population samples. TagSNPs were chosen from SNPs with MAF &gt;5% using LDSelect at <italic>r</italic><sup>2</sup>&gt;0.64</p></caption>
###xml 1289 1289 1289 1289 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="439_2006_160_Fig2_HTML" id="MO2"/>
###xml 1171 1289 1171 1289 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig2"><label>Fig.&#160;2</label><caption><p textid="35">TagSNPs chosen for four population samples. TagSNPs were chosen from SNPs with MAF &gt;5% using LDSelect at <italic>r</italic><sup>2</sup>&gt;0.64</p></caption><graphic position="anchor" xlink:href="439_2006_160_Fig2_HTML" id="MO2"/></fig>
Previous admixture studies suggest that Mexican or Mexican-American populations have European, African, and Asian/Amerindian ancestry, with proportions estimated at approximately 40-60, 3-5, and 30-50%, respectively (Hanis et al. 1991; Long et al. 1991; Collins-Schramm et al. 2004; Salari et al. 2005). To understand how much, if any, diversity information is lost in genotyping SeattleSNPs tagSNPs in a Mexican or Mexican-American sample, we compared tagSNPs determined for a combined population of African- and European-Americans (Fig. 2a, b) to those determined for the Mexican population sample (Fig. 2c) using LDSelect at MAF>5% and r2>0.64. For the Mexican population sample of 20 chromosomes, five tagSNPs were identified for genotyping. All five tagSNPs were represented among tagSNPs chosen for the European- and African-American combined sample and are sufficient to capture the genetic diversity of the locus within the Mexican population sample. Interestingly, the Asian population sample of Chinese, Japanese, and Southeastern Asians is also well represented by CRP tagSNPs chosen from a combined European- and African-American population sample (Fig. 2d). Fig. 2TagSNPs chosen for four population samples. TagSNPs were chosen from SNPs with MAF >5% using LDSelect at r2>0.64
###end p 34
###begin p 35
###xml 105 106 105 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 106 107 106 107 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
TagSNPs chosen for four population samples. TagSNPs were chosen from SNPs with MAF >5% using LDSelect at r2>0.64
###end p 35
###begin title 36
Conclusions
###end title 36
###begin p 37
###xml 143 146 143 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRP</italic>
###xml 297 301 297 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR16">2001</xref>
###xml 330 333 330 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRP</italic>
By re-sequencing ~1,000 chromosomes ascertained from several population samples, we have catalogued novel coding and noncoding DNA variants in CRP. The vast majority of these novel SNPs were rare, consistent with previous observations from candidate gene deep re-sequencing projects (Glatt et al. 2001). We also identified common CRP variation in the Asian and Mexican-descent population samples that overlapped to a great extent with common variation identified by SeattleSNPs in the European-American and African-American population samples.
###end p 37
###begin p 38
###xml 4 7 4 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRP</italic>
###xml 84 87 84 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRP</italic>
###xml 400 403 400 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRP</italic>
###xml 427 430 427 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRP</italic>
###xml 675 679 675 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">2005</xref>
###xml 744 747 744 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRP</italic>
###xml 986 990 986 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR8">2005</xref>
For CRP-specific genetic association studies, these re-sequencing data suggest that CRP common SNPs are in dbSNP and that common disease/common variant study designs using a tagSNP approach can be applied to several population samples with very little population-specific modification. That is, if the most diverse population (e.g., African-descent populations) is considered in tagSNP selection for CRP, genetic diversity for CRP in other population samples will be well represented. However, if only a less diverse population were considered for tagSNP selection (e.g., European-descent populations), one tagSNP (rs3093058) associated with serum CRP levels (Carlson et al. 2005; D. C. Crawford et al., submitted) would not be represented for CRP diversity observed in African-Americans and Mexican-Americans. This issue should be considered when designing genetic association studies in non-European population samples using public SNP resources such as HapMap or dbSNP (Clark et al. 2005).
###end p 38
###begin p 39
###xml 27 30 27 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRP</italic>
###xml 504 508 504 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR21">2001</xref>
###xml 790 794 790 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">2005</xref>
The re-sequencing data for CRP also suggest that coding variation, if not identified in a small re-sequencing sample, is very rare in the general population. These results are not entirely unexpected because the samples sizes used in variation discovery for the present study are based on population genetics theory (i.e., effective population size and mutation rate) and are designed to sufficiently estimate the allele frequency for SNPs with a minor allele frequency of >5-10% (Kruglyak and Nickerson 2001). Indeed, tagSNPs determined in SeattleSNPs were recently genotyped in three larger studies and demonstrated that allele frequencies estimated in the SeattleSNPs sample of 47 individuals is nearly identical to the allele frequencies estimated in the larger studies (Carlson et al. 2005; D. C. Crawford et al., submitted; L. A. Lange et al., in preparation).
###end p 39
###begin p 40
###xml 123 126 123 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRP</italic>
###xml 387 390 387 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRP</italic>
###xml 890 894 890 894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR25">2003</xref>
###xml 1045 1049 1045 1049 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR7">1994</xref>
###xml 1175 1178 1175 1178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRP</italic>
###xml 751 756 <span type="species:ncbi:9606">human</span>
While the coding variation identified in the present study was rare in the general population, there is a possibility that CRP coding variation is strongly associated with a phenotype and could be enriched in a case population. The challenge, of course, is to predict a disease or extreme phenotype given that a putative mutation has been identified. Given that the nonsynonymous SNP in CRP may be damaging to the gene product, we may expect lower levels of serum CRP in heterozygous individuals compared with homozygous individuals for the common allele. Alternately, we may expect individuals heterozygous for these SNPs are unable to mount a proper acute phase response compared with individuals homozygous for the common allele. There is no known human deficiency for CRP, but there are several phenotypes associated with lack of acute phase response (reviewed in Pepys and Hirschfield 2003). Unfortunately, the CRP assay used in NHANES III is not as sensitive compared with currently used assays (Centers for Disease Control and Prevention 1994), so we cannot determine how low the serum CRP levels are for the two individuals who are heterozygous for the nonsynonymous CRP SNP (D. C. Crawford et al., submitted).
###end p 40
###begin p 41
###xml 62 65 62 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRP</italic>
###xml 140 143 140 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRP</italic>
###xml 451 455 451 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">2005</xref>
###xml 471 474 471 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRP</italic>
###xml 520 523 520 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRP</italic>
###xml 562 565 562 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRP</italic>
###xml 594 598 594 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR25">2003</xref>
###xml 619 622 619 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRP</italic>
###xml 56 61 <span type="species:ncbi:9606">human</span>
###xml 155 161 <span type="species:ncbi:9606">humans</span>
###xml 423 428 <span type="species:ncbi:10090">mouse</span>
###xml 480 485 <span type="species:ncbi:10090">mouse</span>
###xml 556 561 <span type="species:ncbi:9606">human</span>
The possibility that deleterious variation may exist in human CRP is intriguing. In addition to providing information for future functional CRP studies in humans, these deep re-sequencing data provide an opportunity to explore the effects of possibly deleterious genetic variation using model organisms and in vitro assays. One obvious choice for modeling SNP effects in context with various environmental exposures is the mouse (MacAuley and Ladiges 2005). However, for CRP, the mouse is not an ideal model because its CRP gene does not function like the human CRP gene (Pepys and Hirschfield 2003). Nevertheless, the CRP example demonstrates the potential usefulness of identifying coding variants through deep re-sequencing that may be taken forward into other meaningful experiments that specialize in function.
###end p 41
###begin p 42
###xml 57 60 57 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRP</italic>
###xml 203 206 203 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRP</italic>
###xml 639 643 639 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">2005</xref>
###xml 658 662 658 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">2004</xref>
###xml 736 740 736 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR17">2004</xref>
###xml 754 758 754 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR30">2005</xref>
###xml 939 944 <span type="species:ncbi:9606">human</span>
In summary, we describe here the genetic architecture of CRP with special emphasis on the detection and characterization of rare variants. While we were able to describe novel nonsynonymous variants for CRP, we were unable to describe these variants at an appreciable frequency when genotyped in the general population making it impossible to explore the impact of these variants on serum CRP. Given this situation, for a quantitative trait such as CRP, it may be more efficient to re-sequence individuals at the extreme low and high end of the distribution in the search for rarer SNPs that impact the phenotype of interest (Cohen et al. 2005; Cohen et al. 2004). In the age of more efficient, high throughput genotyping (Hinds et al. 2004; Shen et al. 2005), it may be that re-sequencing used in conjunction with genotyping using different study designs is required to fully appreciate the spectrum of genetic variants associated with a human phenotype of interest.
###end p 42
###begin title 43
Websites
###end title 43
###begin p 44
EntrezGene 
###end p 44
###begin p 45
NHANES: 
###end p 45
###begin p 46
PolyPhen: 
###end p 46
###begin p 47
SeattleSNPs Program for Genomic Applications: 
###end p 47
###begin p 48
SIFT: 
###end p 48
###begin title 49
Electronic supplementary material
###end title 49
###begin p 50
Supplementary material 1
###end p 50
###begin p 51
Supplementary material 2
###end p 51
###begin p 52
Supplementary material 3
###end p 52
###begin title 53
Acknowledgements
###end title 53
###begin p 54
We thank C.L. Sanders and Dr. X. Qin (NCHS/CDC; Harris Corporation at Falls Church, Virginia) for their assistance on calculating the allele frequency for SNP 2616 genotyped in NHANES III. The findings and conclusions in this report are those of the author(s) and do not necessarily represent the views of the Centers for Disease Control and Prevention. This work was supported by grants N01 ES15478 and U01 HL66682.
###end p 54
###begin title 55
References
###end title 55
###begin article-title 56
###xml 33 38 <span type="species:ncbi:9606">human</span>
Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease
###end article-title 56
###begin article-title 57
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human CRP gene polymorphism influences CRP levels: implications for the prediction and pathogenesis of coronary heart disease
###end article-title 57
###begin article-title 58
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human C-reactive protein (CRP) 1059G/C polymorphism
###end article-title 58
###begin article-title 59
###xml 106 112 <span type="species:ncbi:9606">humans</span>
Additional SNPs and linkage-disequilibrium analyses are necessary for whole-genome association studies in humans
###end article-title 59
###begin article-title 60
Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium
###end article-title 60
###begin article-title 61
Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels
###end article-title 61
###begin article-title 62
###xml 33 38 <span type="species:ncbi:9606">human</span>
Ascertainment bias in studies of human genome-wide polymorphism
###end article-title 62
###begin article-title 63
Multiple rare alleles contribute to low plasma levels of HDL cholesterol
###end article-title 63
###begin article-title 64
Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9
###end article-title 64
###begin article-title 65
###xml 34 39 <span type="species:ncbi:9606">human</span>
Variations on a theme: cataloging human DNA sequence variation
###end article-title 65
###begin article-title 66
###xml 54 59 <span type="species:ncbi:9606">human</span>
A DNA polymorphism discovery resource for research on human genetic variation
###end article-title 66
###begin article-title 67
Mexican American ancestry-informative markers: examination of population structure and marker characteristics in European Americans, Mexican Americans, Amerindians and Asians
###end article-title 67
###begin article-title 68
###xml 37 42 <span type="species:ncbi:9606">human</span>
The patterns of natural variation in human genes
###end article-title 68
###begin article-title 69
C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease
###end article-title 69
###begin article-title 70
Deeper into the genome
###end article-title 70
###begin article-title 71
Screening a large reference sample to identify very low frequency sequence variants: comparisons between two genes
###end article-title 71
###begin article-title 72
Origins of U.S. Hispanics. Implications for diabetes
###end article-title 72
###begin article-title 73
Matching strategies for genetic association studies in structured populations
###end article-title 73
###begin article-title 74
###xml 55 60 <span type="species:ncbi:9606">human</span>
Whole-genome patterns of common DNA variation in three human populations
###end article-title 74
###begin article-title 75
Genome-wide evaluation of the public SNP databases
###end article-title 75
###begin article-title 76
Efficiency and consistency of haplotype tagging of dense SNP maps in multiple samples
###end article-title 76
###begin article-title 77
A novel common single nucleotide polymorphism in the promoter region of the C-reactive protein gene associated with the plasma concentration of C-reactive protein
###end article-title 77
###begin article-title 78
Variation is the spice of life
###end article-title 78
###begin article-title 79
Genetic variation in Arizona Mexican Americans: estimation and interpretation of admixture proportions
###end article-title 79
###begin article-title 80
Approaches to determine clinical significance of genetic variants
###end article-title 80
###begin article-title 81
Association of common CRP gene variants with CRP levels and cardiovascular events
###end article-title 81
###begin article-title 82
###xml 15 20 <span type="species:ncbi:9606">human</span>
Accounting for human polymorphisms predicted to affect protein function
###end article-title 82
###begin article-title 83
C-reactive protein: a critical update
###end article-title 83
###begin article-title 84
###xml 28 33 <span type="species:ncbi:9606">human</span>
The allelic architecture of human disease genes: common disease-common variant...or not?
###end article-title 84
###begin article-title 85
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human non-synonymous SNPs: server and survey
###end article-title 85
###begin article-title 86
Quality and completeness of SNP databases
###end article-title 86
###begin article-title 87
Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus
###end article-title 87
###begin article-title 88
Genetic admixture and asthma-related phenotypes in Mexican American and Puerto Rican asthmatics
###end article-title 88
###begin article-title 89
High-throughput SNP genotyping on universal bead arrays
###end article-title 89
###begin article-title 90
A comparison of Bayesian methods for haplotype reconstruction from population genotype data
###end article-title 90
###begin article-title 91
A new statstical method for haplotype reconstruction from population data
###end article-title 91
###begin article-title 92
Tag SNP selection for association studies
###end article-title 92
###begin article-title 93
The International HapMap Project
###end article-title 93
###begin article-title 94
###xml 23 28 <span type="species:ncbi:9606">human</span>
A haplotype map of the human genome
###end article-title 94
###begin article-title 95
A C-reactive protein promoter polymorphism is associated with type 2 diabetes mellitus in Pima Indians
###end article-title 95
###begin p 96
###xml 0 33 0 33 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Electronic Supplementary Material</bold>
Electronic Supplementary Material
###end p 96
###begin p 97
Supplementary material is available for this article at  and is accessible for authorized users.
###end p 97

